Turkish Journal of Medical Sciences
Volume 39

Number 1

Article 3

1-1-2009

The Effects of Nitric Oxide on Rat Stomach Injury Induced by
Acetylsalicylic Acid
MURAT YAĞMURCA
MUHARREM UÇAR
ERSİN FADILLIOĞLU
HASAN ERDOĞAN
FERAL ÖZTÜRK

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
YAĞMURCA, MURAT; UÇAR, MUHARREM; FADILLIOĞLU, ERSİN; ERDOĞAN, HASAN; and ÖZTÜRK, FERAL
(2009) "The Effects of Nitric Oxide on Rat Stomach Injury Induced by Acetylsalicylic Acid," Turkish Journal
of Medical Sciences: Vol. 39: No. 1, Article 3. https://doi.org/10.3906/sag-0712-22
Available at: https://journals.tubitak.gov.tr/medical/vol39/iss1/3

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

ORIGINAL ARTICLE

Murat YAĞMURCA1
Muharrem UÇAR2
Ersin FADILLIOĞLU3
Hasan ERDOĞAN4
Feral ÖZTÜRK5

Turk J Med Sci
2009; 39 (1): 13-19
© TÜBİTAK
E-mail: medsci@tubitak.gov.tr
doi:10.3906/sag-0712-22

The Effects of Nitric Oxide on Rat Stomach Injury
Induced by Acetylsalicylic Acid*
Aim: Acetylsalicylic acid (ASA, aspirin), which is one of the most frequently used drugs in the world, causes
severe gastric mucosal injury. Nitric oxide (NO) is synthesized from L-arginine by nitric oxide synthase (NOS).
NOS can be inhibited by Nω-nitro-L-arginine methyl ester (L-NAME) and stimulated by supplementing the diet
with L-arginine (L-Arg). The aim of this study was to investigate the role of NO on gastric mucosal injury
induced by ASA.
Materials and Methods: Male Sprague-Dawley rats were divided into seven groups: control, ASA, ASA+LNAME, ASA+L-Arg, ASA+L-Arg+L-NAME, only L-NAME, and only L-Arg groups. After administration of the
drugs, the rats were decapitated and their stomachs were removed and fixed in 10% neutral-buffered
formalin solution.
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Results: Mucosal erosion, intramucosal hemorrhage, inflammatory cell infiltration, gland cell detachment, and
necrosis were observed in the ASA group. It was demonstrated that L-Arg administration decreased the gastric
mucosal injury, whereas L-NAME administration increased the extent and severity of the gastric injury induced
by ASA. L-Arg or L-NAME administration alone did not affect gastric mucosa.
Conclusions: We concluded that NO may have protective effects on gastric mucosal injury induced by ASA.
Key Words: Nitric oxide, stomach injury, acetylsalicylic acid, microscopy

Ratlarda Asetil Salisilik Asitin Neden Olduğu Mide Hasarında Nitrik Oksitin
Etkileri
Amaç: Dünyada en çok kullanılan ilaçlardan biri olan asetilsalisilik asit (ASA) gastrik mukozada önemli
hasarlara yol açmaktadır. Nitrik oksit (NO) nitrik oksit sentaz (NOS) ile L-arjininden sentezlenir. NOS; Nωnitro-L-arjinin metil ester (L-NAME) ile inhibe edilebilir, diyete L-arjinin (L-Arg) eklenmesi ile uyarılabilir. Bu
çalışmanın amacı ASA’nın neden olduğu gastrik mukozal hasar üzerine nitrik oksitin rolünü araştırmaktır.
Yöntem ve Gereç: Erkek Sprague Dawley sıçanlar; kontrol, ASA, ASA+L-NAME, ASA+L-Arg , ASA +L-Arg+LNAME, L-NAME ve L-Arg olmak üzere 7 gruba ayrıldı. İlaçların uygulanmasını takiben kesilen ratlardan alınan
mide kesitleri %10’luk nötral tamponlanmış formalin ile tespit edildi.
Bulgular: ASA grubunda mukozal erozyon, intramukozal hemoraji, iltihabi hücre infiltrasyonu, bez
hücrelerinde nekroz ve dökülme izlendi. L-Arg uygulanmasının ASA’nın yol açtığı gastrik hasarı azalttığı
gösterildi. Diğer taraftan, L-NAME uygulamasının ise ASA’nın yol açtığı gastrik hasarı belirgin olarak artırdığı
tespit edildi. Sadece L-Arg ya da L-NAME uygulanması gastrik mukozayı etkilemedi.
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Sonuç: Bu çalışma ile, ASA ile meydana gelen gastrik mukozal hasarda, NO’nun koruyucu rolü olabileceği
sonucuna varıldı.
Anahtar Sözcükler: nitrik oksit, mide hasarı, asetil salisilik asit, mikroskopi.
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Introduction
Nitric oxide (NO) is synthesized from L-arginine (LArg) amino acid by one of the three isoforms of nitric
oxide synthetase (NOS). NOS-1 is found in the
gastrointestinal tract and neurons (nNOS) (1). The
inducible NOS (iNOS), which is called NOS-2, is an
important isoform that is found in the endothelial cells,
macrophages and neutrophils. iNOS is the isoform that is
induced to increase its synthesis in some pathological
conditions and is responsible for the injury (1). NOS-3,
which is found in endothelial cells, has useful effects for
the organism (1). The stomach has all three isoforms of
NOS. It is suggested that NO causes gastric acid secretion
and gastric mucosal protection through many separate
mechanisms. NO was shown to directly increase gastric
acid secretion. It also increases gastric blood flow via
vasodilatation, which leads to increased mucus secretion.
It was shown in experimental animal studies that NO
production increases when L-Arg is added exogenously
(1-3). NO production from L-Arg can be inhibited with LArg analogues, experimentally. These L-Arg analogues
competitively inhibit NOS enzyme. N -nitro-L-arginine
methyl ester (L-NAME) is the most commonly used NOS
inhibitor.
In this study, we constituted gastric mucosal injury
with acetylsalicylic acid (ASA) in rats and we evaluated the
possible effects of NO on this injury. Its effects were also
evaluated when NO production was suppressed with LNAME and was induced with L-Arg.

Materials and Methods
Animals
Thirty-nine male Sprague–Dawley rats weighing 250350 g were used (180 days old) in the experiments. The
animals were housed in quiet rooms with 12-hour (h)
light–dark cycles (7 am to 7 pm). The experiments were
performed in accordance with the “Guide for the Care and
Use of Laboratory Animals, DHEW Publication No. (NIH)
85-23, 1985” and approved by the local ethical committee
of the Medical School of İnönü University. All experiments
were done at the laboratories of İnönü University.
Animal Treatment Model of ASA-induced Gastric
Mucosal Damage and Experimental Groups
For 18 h before the experiments, the animals were
fasted, but allowed free access to water. Rats were
14
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randomly assigned to one of seven groups: control
untreated rats (n = 7); animals treated with single oral
ASA (Sigma, St. Louis, MO, USA) alone (250 mg/kg) (n =
7); animals treated with single oral ASA (250 mg/kg) +
intraperitoneal (i.p.) injection L-NAME (l5 mg/kg) (Sigma,
St. Louis, MO, USA) (n = 7); animals treated with oral
ASA (250 mg/kg) + i.p. injection L-Arg (500 mg/kg)
(Sigma, St. Louis, MO, USA) (n = 7); animals treated with
oral ASA (250 mg/kg) + i.p. injection L-Arg (500 mg/kg)
+ i.p. injection L-NAME (15 mg/kg) (n = 7); animals
treated with i.p. injection L-NAME (15 mg/kg) (n = 2);
animals treated i.p. injection L-Arg (500 mg/kg) (n = 2).
The animals were sacrificed 2 h after the administration
of ASA. Their stomachs were removed, dissected along
the greater curvature, and rinsed in cold saline solution.
The stomach tissue was stored at -70ºC until biochemical
analyses.
Determination of Gastric Mucosa Tissue Nitric
Oxide Levels with Biochemical Analysis
Nitric oxide has a half-life of only a few seconds
because it is readily oxidized to nitrite (NO2 ) and
subsequently to nitrate (NO3 ), which serve as index
parameters of NO production. The method for
measurement of plasma nitrite and nitrate levels was
based on the Griess reaction (4). Samples were initially
deproteinized with Somogyi reagent. Total nitrite (nitrite
+ nitrate) was measured by spectrophotometry at 545
nm after conversion of nitrate to nitrite by copperized
cadmium granules. A standard curve was established with
a set of serial dilutions of sodium nitrite. The resulting
equation was used to calculate the unknown sample
concentrations.
Histological Examination
Specimens were fixed in buffered 10% formalin and
4% paraformaldehyde solutions and stained. The mucosal
specimens were evaluated qualitatively under light
microscopy (Olympus BH2).
Statistical Analysis
Results were presented as means±SD. Distribution
of the groups was analyzed with one sample
Kolmogorov–Smirnov test. All groups showed normal
distribution, so parametric statistical methods were used
to analyze the data. One-way ANOVA test was
performed and post hoc multiple comparisons were
done with LSD. P values < 0.05 were regarded as
statistically significant.
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ASA+L-NAME Group: The observations made in the
ASA group were seen in broader areas and more sections
in number in this group. In contrast to the ASA group, the
depths of gastric pits were increased and there were
some areas in which gastric surface epithelium lost its
normal structure. In addition, marked vascular dilatation
in the tunica mucosa, hemorrhage in gland lumens and
inflammatory cell infiltrations surrounding particularly
the vessels were observed. Furthermore, hemorrhagic
areas were commonly seen in the tunica submucosa
(Figure 2-C).

Results
Stomach Tissue Nitric Oxide Levels
Comparison of NO levels of gastric tissue according to
the various study groups is shown in Figure 1. NO levels
were found to be increased in ASA, L-Arg and ASA+LArg+L-NAME versus controls (P < 0.05). However, there
was no significant difference between NO levels of the
ASA+L-NAME group versus the control group (P > 0.05).
Histopathological Results
There was no recorded death in any of the
experimental animal groups during the study period.

ASA+L-Arg Group: Focal epithelial losses were seen
in the surface epithelium covering gastric pits. In this
group, no hemorrhage was observed in the lamina
propria or tunica submucosa (Figure 2-D).

Control Group: The gastric tissues were investigated
microscopically and it was observed that tissue samples of
the control group rats showed normal histological
findings (Figure 2-A).

ASA+L-Arg+L-NAME Group: In this group, focal
cellular loss in the gastric mucosa was seen. In addition,
eosinophilic areas including basal parts as well as adjacent
regions stained pale were observed, as seen in the ASA
and ASA+L-NAME groups. Dilatations in the basal regions
of the gastric glands were also more apparent (Figure 2E).

ASA Group: Microscopic investigation revealed focal
erosive area in gastric mucosa and a zone (clear zone) in
the basal regions of the gastric glands stained pale. This
zone was parallel to the surface of the stomach lumen. In
this zone, the structures of the gland were destroyed.
They had disintegrated from the basal lamina and fallen
into the lumen. The nuclei of these cells became smaller
and dense, and their cytoplasms were stained as dark
eosinophilic bodies. Small hemorrhagic areas and patches
of inflammatory cell infiltrations were present in the
lumen of the glands and lamina propria (Figure 2-B).
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L-NAME Group: Stomach sections displayed normal
histological findings (Figure 2-F).
L-Arg Group: Stomach sections displayed normal
histological findings (Figure 2-G).
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Figure 1. Comparison of the stomach tissue NO levels according to groups (P < 0.05 statistically
significant).

15

YAĞMURCA, M et al.

The Effects of Nitric Oxide on Stomach Injury

Turk J Med Sci

Figure 2. Hematoxylin & eosin (HE) staining of stomach in control (A), ASA (B), ASA+L-NAME (C), ASA+L-Arg (D) and ASA+L-Arg+L-NAME (E), LNAME (F), and L-Arg (G) treatment rats. A- An appearance in control rat. Picture shows normal gastric mucosa, surface columnar epithelium
(short arrows), gastric pits (long arrows) and lamina propria (P) (HE X20). B- An appearance in ASA-treated rats. Mucosal damage,
eosinophilic area (E) and clear zone (C) are seen (HE X10). C- An appearance in ASA+L-NAME-treated rats. Mucosal hemorrhage (H) is
seen (HE X20). D- An appearance in ASA+L-Arg-treated rats. Mild mucosal superficial damage is seen (periodic-acid Schiff [PAS]-Alcian blue
X10). E- An appearance in ASA+L-Arg+L-NAME-treated rats. Eosinophilic area (E), clear zone (C) and dilation of the gastric glands
(asterisks) are observed (HE X10). F- An appearance in L-NAME-treated rats, showing normal gastric mucosa (HE X10). G- An appearance
in L-Arg-treated rats, showing normal gastric mucosa (HE X10).
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Discussion
L-NAME inhibits NO synthesis. In contrast, L-Arg
increases NO levels. In our study, it was found that
mucosal damage was higher in the ASA+L-NAME than in
the one ASA-only administered group. In contrast,
mucosal damage was lower in the ASA+L-Arg group. It
was also observed that administration of L-Arg or LNAME alone did not cause any structural impairment.
Therefore, it may be concluded that the damageincreasing effect of L-NAME, which is a NOS inhibitor,
may have been neutralized by the administration of L-Arg
(ASA+L-Arg+L-NAME). Another support for this
hypothesis is the result that gastric mucosal damage in
the ASA+L-Arg+L-NAME group was close to that
observed in the control group.
Although the effect of ASA is supposed to be caused
by the decrease in gastric mucosal blood flow and mucus
secretion and increase in the back diffusion of the acid
(5), the increase of NO level suggests that NO may play
an important role in the mucosal pathology caused by
ASA. Given that the effects of ASA on the gastrointestinal
system are at least partly performed via prostaglandins,
there likely exists a relationship between NO and
prostaglandins (6). A study by Salvemini et al. (7) has
shown that endogenous and exogenous NO increases
PGE2 secretion by direct activation of cyclo-oxygenase
(COX) in fibroblasts. In the report in question, they
showed that NO markedly increased COX activity. Those
authors thought that they might play a key role in the
mutual interaction of pro- and anti-inflammatory
mediators of NOS and COX enzymes. However, in
another study, Ko and Cho (8) found an increase in PGE2
biosynthesis following the inhibition of NOS in the
stomachs of rats. This finding suggests that NO may use
some other ways outside of prostaglandins to exert its
protective effect on gastric mucosa. It has been proposed
that NO has many independent mechanisms to protect
gastric mucosa. The increase in the NO level in the ASA
group shows that some protective mechanisms have been
activated following the ASA administration.
It has been shown that drugs such as indomethacin
and ASA damage gastric mucosa by decreasing blood
flow. It is known that hemorrhage, erosion and ulcers
develop as a result of the decrease in mucosal blood flow.
The best known vascular reaction in response to mucosal
damage is hyperemia against irritant substances (9).
When the mucosa is exposed to an irritant substance the
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blood flow increases. This response is initiated by the
afferent nerve endings under the epithelium (9). These
afferent nerve endings have important functions. With
acid infusion from the stomach lumen to the lamina
propria, these nerve endings localized in this region are
stimulated and these neurons synthesize calcitonin gene
related peptide (CGRP) and send it to submucosal
arterioles. CGRP causes vasodilatation by stimulating NO
secretion and hyperemia following the damage (10). In a
study by Holzer et al. (11), the importance of this
reactive hyperemia was emphasized and shown with the
removal of gastric sensory nerves and increase in the
sensitivity of the stomach to damage-causing agents.
Consequently, this proves the protective significance of
these nerves, vasodilatation and the resulting hyperemia
as a defense mechanism. Another study by Qiu et al. (12)
showed that the decrease in NO levels decreases blood
flow and increases the severity of mucosal damage. The
deficiency of NO initially leads to vasoconstriction,
followed by vasodilatation, and eventually ischemiareperfusion-like condition, and in this process, free
oxygen radicals play an important role. This study also
emphasized that L-NAME increases the damage by
decreasing blood flow.
It was shown that neutrophils play an important role
in the damage of gastric mucosa as a result of nonsteroidal anti-inflammatory drugs (NSAIDs) (13,14).
McCafferty et al. (14) showed that gastric damage caused
by indomethacin was mostly attenuated in neutropenic
rats. Asako et al. (15) also stated that NSAID
administration significantly decreased the leukocyte
invasion in the endothelium of mesenteric venules.
It was stated that gastric damage may be prevented
or at least decreased with the inhibition of neutrophil
adhesion (16). Inflammatory cell infiltration in the ASA
group was significantly increased in the ASA+L-NAME
group in our study. Neutrophil predominance was
obvious in cell infiltration. Inflammatory cell infiltration
was scarce in the ASA+L-Arg group. Andrews et al. (17)
observed that intercellular cell adhesion molecule-1
(ICAM-1) expression increased 30 minutes after ASA and
indomethacin administration. On the other hand, gastric
mucosa damage was mostly prevented with the
administration of antibody against CD18 that is a CAM
and NSAID (18). The importance of neutrophils in
mucosal damage caused by the administration of NSAID
was shown in many studies (18-22). Adhesion of
17
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neutrophils to blood vessels was shown to be prevented
by the effect of NO in the studies conducted by Wallace et
al. (19) and Davies et al. (22). Kubes et al. (23) observed
that adhesion of leukocytes to blood vessels was
increased with the inhibition of NO synthesis. Another
study stated that the chemotaxis of leukocytes to vessels
was inhibited with the administration NO donor (9). Low
damage scores in the ASA+L-Arg group may have been
caused by increased synthesis of NO that may finally have
prevented the adhesion of neutrophils to vessels.
The fact that NO induces its protective effect by
increasing gastric mucus was brought forward by Brown
et al. (24), who stated that NO induced increased gastric
mucus. Wallace et al. (9) observed that NO increased
gastric mucus with the administration of carbachol. These
suggest that NO was synthesized in epithelial cells and the
cholinergic system was included in the synthesis of NO.
NO was also important in the protection of the epithelial
barrier. It was observed in our study that both superficial
and neck mucus cells were damaged with administration
of ASA with periodic acid-Schiff (PAS)-Alcian blue
method. Dye properties were not changed in the noneroded fields.
Increased damage in the ASA+L-NAME group was
attributable to the inhibition of NO synthesis. We
suggest that inhibition of NO synthesis may have
increased damage because NO was an important agent
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for protection of gastric mucosa in our study. Gastric
NO levels were also in good concordance with our
histopathologic results. Increased NO levels in the ASA
group were decreased to control levels with the
administration of L-NAME and increased with the
administration of L-Arg. These results also supported
the possible protective effect of NO in prevention of
damage caused by ASA. L-Arg increases NO as a NO
donor. Administration of L-NAME with L-Arg negated
the inhibition of NOS. Administration of L-Arg without
the administration of L-NAME increased tissue NO
levels.
In conclusion, NO synthesis is inhibited by L-NAME,
and stomach tissue NO levels were decreased.
Histopathologically, mucosal damage caused by ASA was
increased. L-Arg caused a significant increase in NO levels
in stomach tissue. L-Arg administration decreased the
damage caused by ASA. In addition, L-Arg prevented NOS
inhibition by L-NAME. These data suggest that NO donors
may increase the mucosal defense and that use of NO
donors in combination with NSAID may also be useful in
treatment.
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